Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 8/2020

Open Access 01-08-2020 | Giant Cell Arteritis | Systematic Review

The prevalence and impact of depression in primary systemic vasculitis: a systematic review and meta-analysis

Authors: Bradley Pittam, Sonal Gupta, Ashar E. Ahmed, David M. Hughes, Sizheng Steven Zhao

Published in: Rheumatology International | Issue 8/2020

Login to get access

Abstract

Objective

To describe the prevalence of depression among patients with primary systemic vasculitides (PSV); compare prevalence according to vasculitis type and against controls; and examine the impact of depression on PSV outcomes.

Methods

We searched Medline, PubMed, Scopus and Web of Science using a predefined protocol in accordance with PRISMA guidelines. We included all studies that reported the prevalence or impact of depression in PSV. We also included polymyalgia rheumatica (PMR) given its association with giant cell arteritis (GCA). Meta-analyses of prevalence estimates were performed using random-effects models and reported as percentages (95% confidence interval).

Results

We reviewed a total of 15 studies that described the prevalence of depression, categorised into small (n = 10) and large vessel vasculitis (n = 7). Pooled prevalence estimate for depression in a small vessel (predominantly ANCA-associated) vasculitis was 28% (95% CI 20–38%) with significant heterogeneity (I2 = 93%). Depression prevalence in large-vessel vasculitis (Takayasu and GCA/PMR) was 24% (95% CI 17–34%), again with significant heterogeneity (I2 = 96%). One study reported 56% prevalence of depression in medium vessel disease. The prevalence of depression in small vessel vasculitis was higher than healthy controls. In these patients, depression and depressive symptoms were associated with poorer quality of life, adherence, and work disability, but not disease activity or damage.

Conclusion

Depression is highly prevalent among patients with primary systemic vasculitis and associated with poorer outcomes across a range of measures in studies of small vessel disease. Further studies are needed for depression in medium and large vessel vasculitides.
Appendix
Available only for authorised users
Literature
1.
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11CrossRef
2.
Phillip R, Luqmani R (2008) Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 26(5 Suppl 51):S94–104PubMed
3.
Buttgereit F (2020) Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat Rev Rheumatol 16(4):239–246CrossRef
4.
Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T et al (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583–1594CrossRef
5.
Cook MJ, Bellou E, Bowes J, Sergeant JC, O’Neill TW, Barton A et al (2018) The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank. Rheumatology 57(12):2172–2182CrossRef
6.
7.
Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S et al (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatol Oxf Engl 57(5):835–843CrossRef
8.
Carpenter DM, Hogan SL, Devellis RF (2013) Predictors of medication non-adherence for vasculitis patients. Clin Rheumatol 32(5):649–657CrossRef
9.
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012CrossRef
10.
Stern AF (2014) The hospital anxiety and depression scale. Occup Med Lond 64(5):393–394CrossRef
11.
12.
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613CrossRef
13.
Hajj-Ali RA, Wilke WS, Calabrese LH, Hoffman GS, Liu X, Bena J et al (2011) Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res 63(6):827–833CrossRef
14.
Li L, Neogi T, Jick S (2018) A cohort study of comorbidity in patients with granulomatosis with polyangiitis. Rheumatol Oxf Engl 57(2):291–299CrossRef
15.
Yun J-D, Ha J, Kim S, Park HA, Yoo J, Ahn SS et al (2019) Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Rheumatol 38(12):3485–3491CrossRef
16.
Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DGI (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49(6):826–837CrossRef
17.
Grayson PC, Amudala NA, Mcalear CA, Leduc RL, Shereff D, Richesson R et al (2013) Illness perceptions and fatigue in systemic vasculitis: fatigue and illness perceptions in vasculitis. Arthritis Care Res 65(11):1835–1843CrossRef
18.
Brezinova P, Englbrecht M, Lovric S, Sämann A, Strauss B, Wolf G et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52(10):1856–1864CrossRef
19.
Basu N, Jones GT, Fluck N, MacDonald AG, Pang D, Dospinescu P et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49(7):1383–1390CrossRef
20.
Mcclean A, Morgan M, Harper L, Basu N, Jones D, Bosch J (2013) Severe fatigue and psychological morbidity in ANCA-associated vasculitis. Presse Med 42(4):749–750CrossRef
21.
Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O et al (2013) Impaired quality of life, disability and mental health in Takayasu’s arteritis. Rheumatology 52(10):1898–1904CrossRef
22.
Alibaz-Oner F, Can M, Ilhan B, Polat O, Mumcu G, Direskeneli H (2013) Presence of fibromyalgia in patients with Takayasu’s arteritis. Intern Med 52(24):2739–2742CrossRef
23.
Vivekanantham A, Blagojevic-Bucknall M, Belcher J, Mallen CD, Hider SL, Clarkson K (2018) How common is depression in patients with polymyalgia rheumatica? Clin Rheumatol 37(6):1633–1638CrossRef
24.
Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Mallen CD et al (2018) Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care. Clin Rheumatol 37(6):1639–1644CrossRef
25.
Li L, Neogi T, Jick S (2017) Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatol Oxf Engl 56(5):753–762
26.
Hajj-Ali RA, Saygin D, Ray E, Morales-Mena A, Messner W, Sundaram P et al (2019) Long-term outcomes of patients with primary angiitis of the central nervous system. Clin Exp Rheumatol 117(2):45–51 (37 Suppl)
27.
Hinojosa-Azaola A, Jimenez-Gonzalez A, Alcocer-Castillejos N (2018) Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis. Rheumatol Int 38(4):631–640CrossRef
28.
Basu N, McClean A, Harper L, Amft EN, Dhaun N, Luqmani RA et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73(1):207–211CrossRef
29.
Basu N, Erwig LP, Reid DM, Macfarlane GJ, Jones GT, Mcclean A et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol UK 53(5):953–956CrossRef
30.
Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Oxf Engl 52(12):2136–2148CrossRef
31.
Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ (2020) Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol 39(1):217–225CrossRef
32.
33.
Grygiel-Gorniak B, Limphaibool N, Puszczewicz M (2019) Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry Clin Neurosci 73(6):302–316CrossRef
34.
DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160(14):2101–2107CrossRef
35.
36.
Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S et al (2016) Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol 35(3):733–739CrossRef
37.
Ahmed AE, Lowe D, Kirton JA, O’Brien MR, Mediana A, Frankland H et al (2016) Development of a rheumatology-specific patient concerns inventory and its use in the rheumatology outpatient clinic setting. J Rheumatol 43(4):779–787CrossRef
Metadata
Title
The prevalence and impact of depression in primary systemic vasculitis: a systematic review and meta-analysis
Authors
Bradley Pittam
Sonal Gupta
Ashar E. Ahmed
David M. Hughes
Sizheng Steven Zhao
Publication date
01-08-2020

Other articles of this Issue 8/2020

Rheumatology International 8/2020 Go to the issue

Observational Research

Analysis of ocular surface damage and visual impact in patients with primary and secondary Sjögren syndrome

Observational Research

Association between statin use and incidence of relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-center retrospective cohort study

Review

Implications of COVID-19 in pediatric rheumatology

Observational Research

Shear wave elastography as a new method to identify parotid lymphoma in primary Sjögren Syndrome patients: an observational study

Correspondence

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic

Observational Research

The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits